Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Gastrointestinal Collaboration and Licensing Deals 2016-2026" report has been added to ResearchAndMarkets.com's offering.

The definitive benchmark for gastrointestinal dealmaking

Gastrointestinal partnering spans a broad range of indications, modalities, and stages of development, with deal structures reflecting the diversity of disease areas and therapeutic approaches across the space.

This report provides a comprehensive and structured analysis of 432 gastrointestinal collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards
The report enables a precise understanding of how gastrointestinal deals are structured in practice, allowing you to:

Benchmark comparable transactions with confidence
Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
Define realistic market parameters
Clear insight into how deal terms vary by stage, asset type, and partner profile
Support valuation and structuring decisions with evidence
Ground internal discussions in real transaction data rather than assumptions
Understand how leading companies approach dealmaking
Visibility into partner behaviour and recurring deal structures across a diverse and evolving therapeutic landscape
Full visibility into deal structure and execution

Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

Rights granted and retained
Development and commercialization responsibilities
Financial structures and payment triggers
Key contractual provisions and protections

This level of transparency is critical to understanding how value, risk, and control are allocated within gastrointestinal partnerships, particularly across chronic and heterogeneous disease settings.

Designed for real-world BD and strategy use

The report is widely used to:

Structure and benchmark live transactions
Prepare for negotiations with well-defined market context
Evaluate partnership opportunities and counterparties
Support internal strategy with robust, defensible data

What's included?

432 gastrointestinal collaboration and licensing deals
Financial terms, including upfronts, milestones, and royalties where disclosed
Fully searchable deal directory (by company, therapy, and technology)
Direct access to SEC-filed agreements and source documents
Analysis of deal trends, key transactions, and active dealmakers
A trusted, evidence-based reference for gastrointestinal dealmaking

Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how gastrointestinal partnerships are structured, negotiated, and valued.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gastrointestinal dealmaking
2.1. Introduction
2.2. Gastrointestinal partnering over the years
2.3. Gastrointestinal partnering by deal type
2.4. Gastrointestinal partnering by industry sector
2.5. Gastrointestinal partnering by stage of development
2.6. Gastrointestinal partnering by technology type
2.7. Gastrointestinal partnering by therapeutic indication

Chapter 3 - Financial deal terms for gastrointestinal partnering
3.1. Introduction
3.2. Disclosed financials terms for gastrointestinal partnering
3.3. Gastrointestinal partnering headline values
3.4. Gastrointestinal deal upfront payments
3.5. Gastrointestinal deal milestone payments
3.6. Gastrointestinal royalty rates

Chapter 4 - Leading gastrointestinal deals and dealmakers
4.1. Introduction
4.2. Most active in gastrointestinal partnering
4.3. List of most active dealmakers in gastrointestinal
4.4. Top gastrointestinal deals by value

Chapter 5 - Gastrointestinal contract document directory
5.1. Introduction
5.2. Gastrointestinal partnering deals where contract document available

Chapter 6 - Gastrointestinal dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by gastrointestinal therapeutic target

Deal directory

Deal directory - Gastrointestinal deals by company A-Z
Deal directory - Gastrointestinal deals by technology type
Deal type definitions

Companies Featured

4D Pharma
4SC
9 Meters Biopharma
Aayam Therapeutics
Abbvie
Ab E Discovery
Aclipse Therapeutics
AdaptivEndo
AdaptVac
Adiso Therapeutics
ADL Bionatur Solutions
Advanced Biological Laboratories
Aerpio Pharmaceuticals
Aevi Genomic Medicine
AgomAb Therapeutics
AIG Hospitals
AI Medical Service
Akebia Therapeutics
Alba Therapeutics
Alfasigma
Alimentiv
Alivio Therapeutics
Allergan
Allied Digestive Health
Alma Bio Therapeutics
Altos Group
Alvit LCS Pharma
Alvotech
Amarex Clinical Research
Ambry Genetics
Ambu
Amgen
AnimalBiome
Anokion
Antibe Therapeutics
Apogee Biotechnology
Applied BioMath
Arcadia Consumer Healthcare
Ardelyx
Arena Pharmaceuticals
Ariel Precision Medicine
Aristea Therapeutics
Artizan Biosciences
Asahi Kasei
AscentX Medical
Aslan Pharma
Assembly Biosciences
Associazione Poic e Dintorni APS
Astellas Pharma
AstraZeneca
Asymchem Laboratories
Athos Therapeutics
Atlantic Healthcare
Australasian Gastro Intestinal Research Foundation
Aziyo Biologics
AzurRx BioPharma
Back-A-Line
Bausch Health Companies
Baxter International
Bazelet
BDD Pharma
Beacon Discovery
BenevolentAI
Bharat Biotech
BigHat Biosciences
Bill and Melinda Gates Foundation
BinnoPharm
Bio-Me
Bio-Rad Laboratories
Bio-Thera Solutions
BioClinica
Biocodex Microbiota Foundation
BioDelivery Sciences
Biodexa Pharmaceuticals
Biofortis
Biogen
Biohaven Pharmaceuticals
Biolojic Design
BiomeBank
BioMed X Innovation Center
Biomerica
Biomica
BiomX
BioRap Technologies
Biostage
BioSurfaces
Boehringer Ingelheim
Boston Pharmaceuticals
Braintree Laboratories
Bridge Biotherapeutics
Brigham and Women's Hospital
Bristol-Myers Squibb
C4X Discovery
California Institute of Technology
Calypso Biotech
Camargo Pharmaceutical Services
CannaKids
Cannex Scientific
Cantel Medical
Capsulomics
Captor Therapeutics
Cara Care
Carbiotix
Case Western Reserve University
Catholic University Leuven
CB2 Therapeutics
Cedars-Sinai Medical Center
Celgene
Celiac Disease Foundation
Celltrion
Celsius Therapeutics
Censis Technologies
Cerevance
Cernostics
Charles River Laboratories
Cheplapharm Arzneimittel
Chime Biologics
Chinese University of Hong Kong
Chong Kun Dang
CHU Sainte-Justine
Cipher Pharmaceuticals
Cipla
Cleveland Clinic
Clinical Enterprise
CN Bio
Codexis
Collplant
ConvaTec
Cook Biotech
Cooper Pharma
Cornell University
Cosmo Pharmaceuticals
COUR Pharmaceutical
Creapharm
CRH Medical
Crohn's and Colitis Foundation of America
CRS Bio
Curant Health
CURE Pharmaceutical
Cyclerion Therapeutics
Cytocom
CytoReason
Daewoong Pharmaceutical
Daiichi Sankyo
Dalriada Drug Discovery
Danish Innovation Fund
DayTwo
Debiopharm
Deciphex
Delphi Genetics
Department of Defense
Dermira
Dignify Therapeutics
Diversigen
DNAnexus
Dong-A ST
Dr. Falk Pharma
Dr. Reddy's Laboratories
Duke Clinical Research Institute (DCRI)
Duke University
EA Pharma
Earendil Labs
ECM Therapeutics
Eisai
Elanco
Eli Lilly
Emtora Biosciences
EndoLogic
enGene
Engitix
Ensho Therapeutics
Entera Health
Enterome Bioscience
Entrinsic Health Solutions
Equillium
EsoCap
Esteve
EtectRx
Eton Pharmaceuticals
Eunice Kennedy Shriver Institute of Child Health and Human Development
European Union
Evoke Pharma
Evolve BioSystems
Evommune
EVOQ Therapeutics
Evotec
Faes Farma
Felix Biotechnology
Ferring Pharmaceuticals
Finch Therapeutics
First Wave Bio
Food Marble Digestive Health
Formation Bio
Fosun Pharmaceutical
Foundation for Celiac Disease Outcome Measures
French National Institute for Agricultural Research
Fresenius Kabi Pharmaceuticals
FSD Pharma
Fujifilm Kyowa Kirin Biologics
Functional Gut Diagnostics
FutureGen Biopharm
Future Pak
Galapagos
Gedeon Richter
Genentech
Geneoscopy
General Automation Lab Technologies
Genetic Analysis
Genomic Biopharma
Genten Therapeutics
GentiBio
Georgia State University
Giiant Pharma
Gilead Sciences
Ginkgo BioWorks
GI OnDEMAND
GI Partners of Illinois
GI Reviewers
Gossamer Bio
Greenstone Biosciences
GSK
Gusto Global
Hadasit Bioholdings
Haisco Pharmaceutical
Halozyme Therapeutics
Harvest Capital Strategies
Helsinn Healthcare
Helsinn Therapeutics
Hepion Pharmaceuticals
HiFiBio
Highland Therapeutics
HK inno.N
Hollister-Stier Labs
Holobiome
Horizon Europe
Hoth Therapeutics
Hudson Institute of Medical Research
Hyloris Pharmaceuticals
I-mab
Iambic Therapeutics
Idera Pharmaceuticals
Illumina
IMIDomics
Immunai
Immune Pharmaceuticals
Immune Therapeutics
ImmuNext
Immunic
ImmunogenX
Imperial College London
InDex Pharmaceuticals
Innate Pharma
Innovate Biopharmaceuticals
Innovate UK
Innovation Pharmaceuticals
Innovet
Inotrem
InQpharm
Institut Gustave Roussy
Instituto de Ciencias Farmaceuticas
Intact Therapeutics
Intas Pharmaceuticals
International Centre for Diarrhoeal Disease Research
Intract Pharma
Intrexon
IntroMedic
InveniAI
Ionis Pharmaceuticals
Ipsen
IQVIA
Ironwood Pharmaceuticals
ISOThrive
Iterative Health
Iterative Scopes
Jaguar Health
Janssen Biotech
Janssen Pharmaceuticals
Janssen Pharmaceutica NV
Janssen Research & Development
Janssen Sciences
Jiangsu Carephar Pharmaceutical
Jitsubo
Johns Hopkins University
Johnson & Johnson
Johnson & Johnson Consumer Companies
Johnson & Johnson Innovation
JSR
Juntendo University
Juventas Therapeutics
Kaken Pharmaceutical
Kallyope
Kansas University Medical Center (KUMC)
Karolinska Institute
Keio Gijuku University
Kenneth Rainin Foundation (KRF)
Kings College London
Knight Therapeutics
Korea Pharma
Kwang Dong Pharmaceutical
Kyowa Hakko Kirin
Laboratories Acbel
Lahey Hospital & Medical Center
Lamassu Pharma
Landos Biopharma
Leona M and Harry B Helmsley Charitable Trust
Les Laboratoires Servier
LianBio
LimmaTech Biologics
LiveLeaf
LMU University Hospital Munich
LNC
Lucid Diagnostics
Luminex
Lupin
Lynx.MD
Mabwell Bioscience
Magellan Health Services
Marinomed Biotechnologie
Martin Pharmaceuticals
Massachusetts General Hospital
Massachusetts Institute of Technology
Mayo Clinic
McMaster University
Medgenics
MediBeacon
Medical University of Graz
Medical University of Vienna
MedImmune
Medtronic
Meiji Seika
Memorial Hermann Health System
Memorial Sloan Kettering Cancer Center
Merck and Co
Mesoblast
Metabiomics
Metabolon
Microba Life Sciences
Microbiotica
Millennium
Mimetas
Mission Cure
MiTest Health
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
Monash University
Morphic Therapeutic
Mor Research Applications
Moss Genomics
Motus GI Medical Technologies
MultiPlan
Mundipharma
MyBiotics Pharma
Mylan Laboratories
Mylan Pharmaceuticals
Napo EU
Napo Pharmaceuticals
National Heart
Lung and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
National Resilience
Nektar Therapeutics
Neolaia Bio
Neoteryx
Nestle Health Science
NeurAxis
Neurogastrx
New Day Diagnostics
Newsoara Biopharma
Nexilico
NexOptic
Nima
Nipro Corporation
Norgine
Northeastern University
Northwestern University
North Zealand University Hospital
Novartis
Novartis Institute for Tropical Diseases
Novome Biotechnologies
NuBiyota
Numab
NuMedii
Numerate
Nutricion
Nvidia
NYU Langone Medical Center
OMass Therapeutics
OmniVision Technologies
Onegevity
One GI
Orbis Medicines
OSE Immunotherapeutics
Otsuka America Pharmaceutical
Ovation
Owlstone Medical
Palisade Bio
Panaxia
Paragon Bioservices
Parexel
Parexel Biotech
Parvus Therapeutics
Path BioAnalytics
PAVmed
PEAR Therapeutics
Pendopharm
Penn State Microbiome Center
Pfizer
PharmaBiome
PharmaCare Management
PhaseV
Phathom Pharmaceuticals
PlantEXT
Pliant Therapeutics
Portal Instruments
PPD
Pragma Bio
Prana Biotechnology
PredictImmune
Premier Inc
Prescient Medical
Previse
PRISM BioLab
Probi
Processa Pharmaceuticals
Progenity
Prometheus Biosciences
Prometheus Laboratories
Protagonist Therapeutics
Proteic Bioscience
Provention Bio
PureTech Health
Purnovate
PvP Biologics
Quadri Pharmaceuticals
Qualicaps
Qu Biologics
Quell Therapeutics
Quotient Clinical
Quotient Therapeutics
Rafa Pharmaceuticals
Ramot at Tel Aviv University
Rani Therapeutics
Rasayana Therapeutics
Rebiotix
RedHill Biopharma
Regeneron Pharmaceuticals
Regentys
Renexxion
ReproCell
Rho
Ritter Pharmaceuticals
Roche
Roquette
Royal College of Surgeons (Ireland)
Salix Pharmaceuticals
Samsung Bioepis
Sandoz
Sanofi
Sano Genetics
Satisfai Health
SciCann Therapeutics
Scipher Medicine
Sebela Pharmaceuticals
Second Genome
Seed Mena
Selexis
Seres Therapeutics
Serosep
Shandong Luoxin Pharma
Sheba Medical Center
Shionogi
Shire Pharmaceuticals
Siemens Healthineers
Signum Surgical
Simcere Pharmaceuticals
Simulations Plus
Sinorda Biomedicine
Sinovant Sciences
Siolta Therapeutics
SomaLogic
SonarMD
Sonoma BioTherapeutics
Sosei
Sosei Heptares
Spaulding Clinical Research
Stanford University School of Medicine
Starton Therapeutics
Statera Biopharma
Stella Diagnostics
Stoked Bio
Strand Life Sciences
Structural Genomics Consortium
Sun Genomics
SunRock Biopharma
Suono Bio
Sutter Health
Swiss Integrative Center for Human Health
Swixx Biopharma
Symbiotix Biotherapies
Synergy Pharmaceuticals
Synlogic
Synthetic Biologics
Synthon
Takeda Pharmaceutical
Tantu Therapeutics
TARGET PharmaSolutions
Telcon RF Pharmaceuticals
Tetra Bio-Pharma
Teva Pharmaceutical Industries
Teva Pharmaceuticals USA
Texas A&M Health Science Center
The Crohn's and Colitis Foundation of Canada
Theradiag
Theravance
Theravance Biopharma
Theriva Biologics
The Vancouver Island Health Authority
Thorne Research
TiGenix
Tissium
Tivic Health Systems
Tiziana Life Sciences
TScan Therapeutics
Twist Bioscience
Ubie
Unilever
UniQuest
United Digestive
Universite catholique de Louvain
University Gastroenterology
University Hospital of Leuven
University of Adelaide
University of Augsburg
University of Birmingham
University of British Columbia
University of Calgary
University of California
San Diego
University of California Los Angeles
University of California San Francisco
University of Manitoba
University of Massachusetts
University of Michigan
University of North Carolina
University of Oslo
University of Oxford
University of Pennsylvania
University of Pittsburgh
University of Sherbrooke
University of Tokyo
University of Washington
University of Windsor
Upadia
US Government
Utrecht University
Valbiotis
Valneva
Vcell Healthcare
V ClinBio
VectivBio
Vedanta Biosciences
Verily
Vertex Pharmaceuticals
Viatris
VIPUN Medical
Virginia Catalyst
Virgo Surgical Video Solutions
Virios Therapeutics
Vital Food Processors
Vital Therapies
Vivante Health
Vivelix Pharmaceuticals
Vivtex
Vizient
Washington University in St Louis
WuXi Biologics
Yale University
Zealand Pharma
Zedira
Zentiva
Zydus Lifesciences

For more information about this report visit https://www.researchandmarkets.com/r/k58x7y

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900

Gastrointestinal Collaboration and Licensing Agreements Benchmark Report 2026: Access to Structured Analysis of 432 Deals Signed Since 2016 - Finance, Indications, Modalities, Stages of Development